Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radionuclide therapy revisited.

C A Hoefnagel1

  • 1Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam.

European Journal of Nuclear Medicine
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Therapeutic nuclear medicine, or radionuclide therapy, offers a promising cancer treatment. This approach uses targeted radiopharmaceuticals for effective tumor management with fewer side effects than traditional therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.

European journal of nuclear medicine·2014
Same author

Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging.

Clinical medicine. Oncology·2011
Same author

The pharmacokinetics of ¹³¹I-rituximab in a patient with CD20 positive non-Hodgkin Lymphoma: evaluation of the effect of radioiodination on the biological properties of rituximab.

Human antibodies·2011
Same author

[Added value of prone position technique for PET-TAC in breast cancer patients].

Revista espanola de medicina nuclear·2010
Same author

Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies.

European journal of nuclear medicine and molecular imaging·2009
Same author

[Regional lymph nodes at a distance].

Nederlands tijdschrift voor geneeskunde·2008
Same journal

[Not Available].

European journal of nuclear medicine·2016
Same journal

A Window on Latin America.

European journal of nuclear medicine·2016
Same journal

Erratum: Eur J Nucl Med (1999) 26: 686-692.

European journal of nuclear medicine·2016
Same journal

Nuclear medicine in the next decade.

European journal of nuclear medicine·2014
Same journal

Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis.

European journal of nuclear medicine·2014
Same journal

(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.

European journal of nuclear medicine·2014
See all related articles

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiopharmaceutical Therapy

Background:

  • Therapeutic nuclear medicine is emerging as a significant treatment in oncology.
  • Radiopharmaceuticals are increasingly used for both diagnosis and therapy in cancer management.

Purpose of the Study:

  • To review available therapeutic radiopharmaceuticals for cancer treatment.
  • To discuss the clinical application and results of radionuclide therapy.
  • To highlight the advantages of radionuclide therapy over conventional treatments.

Main Methods:

  • Review of radiopharmaceuticals based on their cellular accumulation site.
  • Analysis of clinical outcomes from current therapeutic applications.
  • Comparison of radionuclide therapy with chemotherapy and external beam radiotherapy.

Related Experiment Videos

Main Results:

  • Various radiopharmaceuticals are effective in targeting tumors.
  • Radionuclide therapy shows positive clinical responses.
  • The procedure is minimally invasive with reduced toxicity and late effects.

Conclusions:

  • Radionuclide therapy is an attractive and viable option for managing malignant diseases.
  • It also presents a treatment option for select benign disorders.
  • Its favorable safety profile enhances its role in modern cancer care.